The role of SUCNR1 activation in common diabetic complications, including diabetic nephropathy, retinopathy, and NAFLD, all of which have a significant impact on patient health, is the focus of ongoing research and the following subsections. This evidence concerns the gene SUCNR1 and metabolic dysfunction-associated steatotic liver disease.